StonvexLoading…
StonvexCore line items from ASTS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-08-10 | Annual 2024 2024-12-31 | Q1 2023 2023-03-31 | Annual 2022 2022-12-31 | Q3 2022 2022-09-30 |
|---|---|---|---|---|---|
Revenue | $36.03M | $13.82M | $2.39M | $13.82M | $13.82M |
Operating Income | Not available | $-525.00M | $-45.10M | $-102.50M | $-77.28M |
Net Income | Not available | $-300.08M | $-16.32M | $-31.64M | $-23.41M |
EPS (Diluted) | $-0.27 | Not available | Not available | Not available | $-0.45 |
Total Assets | Not available | $954.56M | $400.72M | $438.37M | $386.27M |
Total Liabilities | Not available | $285.42M | $83.80M | $78.55M | $89.59M |
Cash & Equivalents | Not available | $564.99M | $185.04M | $238.59M | $198.87M |
Free Cash Flow OCF − CapEx | Not available | $-300.27M | $-53.12M | $-213.75M | $-167.27M |
Shares Outstanding | Not available | 154.50M | Not available | Not available | 52.29M |